ALDXAldeyra Therapeutics, Inc.

$290M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$96,305

Operating Income

-$63M

Net Income

-$61M

EPS (Diluted)

$-2.24

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$76M

Total Liabilities

$27M

Stockholders' Equity

$48M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$96,305	-$71,003	-35.6%
Operating Income	-$63M	-$40M	-58.9%
Net Income	-$61M	-$39M	-56.4%

ALDX FY 2019 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena